KEAP1 and Parkinson disease: In conclusion, this study evidence that LRRK2 plays a central role in the pathogenesis of Parkinson’s disease by orchestrating microglial neuroinflammation and ferroptosis through the p62-Keap1-Nrf2 signaling cascade.